Skip to main content

Embattled Elementis CEO to step down

19th November 2024

Submitted by:

Andrew Warmington

UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.

The company said that Waterman “will be treated in accordance with the company’s remuneration policy and his service agreement for the remaining term of his contract. Full details of this will be disclosed on the website “in due course”, it added. Waterman has led Elementis for nearly nine years since taking the role in 2016.

Over the past 12 months, the company has come under pressure from ‘activist’ shareholders over the past 12 months, with some demanding that he be replaced. In November 2023, Franklin Mutual Advisers published an open letter to board chairman John O’Higgins, calling for Elementis to put itself up for sale. It accused the company of “a shocking amount of shareholder value destruction”, mainly as a result of recent acquisitions.

This pressure increased in April2024, when Gatemore Capital Management published a similar letter, stating that there was a huge gulf between the firm’s fundamental strengths and its “persistently weak share price”. Having failed to get anywhere by engaging with the board, it said that was going public about how Elementis should act “to rebuild investor confidence and unlock significant value for its shareholders”.

Under Waterman, Gatemore contended, Elementis had total shareholder returns 86% lower than its peers and 76% lower than the FTSE 250, despite three takeover approaches boosting the share price. Elementis responded that: “The board continues to believe that shareholder value is best driven by a focus on delivering the substantial actions that are currently being progressed at pace throughout the business.”

In July, Gatemore published a second letter, describing this as “wholly inadequate”. It called for the cost-savings programme to be accelerated, Waterman replaced and a strategic review, including a potential disposal of the Talc business. Failing this, it would look to join other shareholders to push through the changes it wanted. It also noted that Waterman had sold 350,000 shares in the company, which it called “tone-deaf in the context of extensive cost cuts” and sent “an extremely poor signal to shareholders on the CEO’s views on the future prospects of the business”. Over the course of 18 years at Elementis, Gatemore noted, Waterman had earned £14 million.

Gatemore welcomed the announcement of Waterman's departure saying it "marks the implementation of the third step we called for". The others were already announced in August, though the outcome with regard to the Talc business remains to be seen. "Additionally, we remain actively engaged with fellow shareholders to ensure the optimal composition of the board and to determine who is best suited to lead the process of selecting a new CEO to drive the company forward," said managing partner Liad Meidar.

Elementis mainly supplies the personal care sector, notably cosmetic and antiperspirant actives; it is the world market leader in the latter field. 85% of its products are of natural origin. Coatings and paper are other key markets.

“Over the past nine years it has been my privilege to lead Elementis as we have transformed the group into a higher quality, more focused speciality chemicals business,” Waterman stated. “The company is now well positioned for future success … I am confident that performance will further improve through 2025 and 2026, making now an appropriate time for a leadership transition.”

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after a week after the latter declined to engage with it.

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington